BenSam, I looked very closely at both LDR and HDR after I had made my decision to go with BT as my primary treatment. I did a huge amount of research into these two modalities, and ultimately chose LDR based on a number of points:
*LDR-BT is primarily administrated as a monotherapy in early detected, low to intermediate risk prostate cancer, which is what I presented. HDR-BT is usually applied along with external beam radiation to patients with prostate tumors non qualified by strict stage terms and that present the potential of cancerous cells escaping the capsule.
*HDR-BT is relatively new as a monotherapy, and at the moment there are limited data about
the results and the complication rates in longer follow-up as compared to LDR-BT with experience and results of over 15 years and more.
JNF mentioned seed shifting, which in the early days of LDR-BT was a potential albeit small risk factor. Currently in LDR-BT there is an advanced technique of seeds implantation called stranded seeds. In this technique, the seeds are embedded in a polymer strand spaced from 5 mm to over 50 mm apart, and placed in typically an 18-gauge needle. The main advantages of this technique is significant improvement in D90 parameter without increasing of toxicity rate and even less number of seeds migration incidences.
Finally, here's a link to a study I found in the March 2013 Journal of Contemporary Brachytherapy that provides a great comparison of the two modalities:
www.ncbi.nlm.nih.gov/pmc/articles/PMC3635047/From the "Conclusions" of this article: "At present, the available clinical data with these two techniques suggests that they are equally effective, stage for stage, in providing high tumor control rates." While I made my choice of LDR-BT, I would agree with this conclusion as well as with JNF's point about
choosing the "best" practitioner.
Continued best.
Yoop